Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Alzheimer's Disease

Clinical Trial Details

Overview

Research Study Summary

Patients are needed to participate in a clinical research study of Galantamine and Donepezil to evaluate Alzheimer's Disease

Research Study Title

Effects of Galantamine and Donépézil on the Amount and the Quality oh the Sleep in Patients Suffering From Alzheimer Disease.

Purpose

The aim of the study is the analysis of two inhibitors of Ach-E: galantamine and donépézil in over 65 years' old patients suffering from Alzheimer disease (MMSE between 20 and 26) without Alzheimer's medication.

To Learn more
Phase

1

Gender

Both Male and Female

Age

65 and up

Overall Status

Recruiting

Lead Sponsor

University Hospital, Clermont-Ferrand

Duration

66 Months

Facility Type

N/A

Eligibility

Both Male and Female ages 65 Years and up

Inclusion Criteria:

  • 65 and over years old

  • Patients suffering from Alzheimer disease

  • Patient living with someone at home

  • Written consent given

Exclusion Criteria:

  • Galantamine or Donepezil hypersensibility

  • Patient living alone and in a medicalized structure

  • Concomitant medication

  • Chronical diseases

Site Locations (1)

Country State City Zip Facility and Contact
France Clermont-Ferrand 63003 CHU Clermont-Ferrand
Patrick Lacarin
placarin@chu-clermontferrand.fr

Contact

Lacarin Patrick
04.73.75.11.95

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

NCT ID: NCT00750529

Date Last Changed: September 2, 2013

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Some study summaries have been edited for clarity purposes to make them easier to understand. View more study details here.